These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The clinical relevance of memantine use]. Sobów T. Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296 [Abstract] [Full Text] [Related]
4. Therapies for Alzheimer's disease. Melnikova I. Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date. Bullock R. Alzheimer Dis Assoc Disord; 2006 May; 20(1):23-9. PubMed ID: 16493232 [Abstract] [Full Text] [Related]
6. [Antibodies, antihypertensive drugs, antioxidants. Can they prevent Alzheimer disease?]. MMW Fortschr Med; 2003 Aug 21; 145(33-34):60. PubMed ID: 14526584 [No Abstract] [Full Text] [Related]
7. Memantine (Namenda) for moderate to severe Alzheimer's disease. Ables AZ. Am Fam Physician; 2004 Mar 15; 69(6):1491-2. PubMed ID: 15053415 [No Abstract] [Full Text] [Related]
9. [Little behavior improvement with memantine]. Potz-Biedermann C. Med Monatsschr Pharm; 2005 Nov 15; 28(11):413-4. PubMed ID: 16309030 [No Abstract] [Full Text] [Related]
10. Memantine for dementia? Drug Ther Bull; 2003 Oct 15; 41(10):73-6. PubMed ID: 14593973 [Abstract] [Full Text] [Related]
11. Memantine hydrochloride. Witt A, Macdonald N, Kirkpatrick P. Nat Rev Drug Discov; 2004 Feb 15; 3(2):109-10. PubMed ID: 15040575 [No Abstract] [Full Text] [Related]
12. Memantine in the treatment of dementia. Maggiore C, Locatelli L, Grandi FC, Pizzolato G, Cochrane Neurological Network. Neuroepidemiology; 2007 Feb 15; 28(2):118-9. PubMed ID: 17409774 [No Abstract] [Full Text] [Related]
13. [Mechanisms of action of Alzheimer medications]. Alhainen K. Duodecim; 2003 Feb 15; 119(20):1959-66. PubMed ID: 14640001 [No Abstract] [Full Text] [Related]
14. Memantine: the next trend in academic performance enhancement? Ota KS, Godwin T. J Am Osteopath Assoc; 2006 Jun 15; 106(6):358-9. PubMed ID: 16790543 [No Abstract] [Full Text] [Related]
15. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A, Alfaro V. Rev Neurol; 2006 Jun 15; 42(10):607-16. PubMed ID: 16703529 [Abstract] [Full Text] [Related]
16. Stroke, Alzheimer's patients may benefit from AIDS dementia drug. Dent Today; 1997 Feb 15; 16(2):29. PubMed ID: 9560599 [No Abstract] [Full Text] [Related]
17. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN. J Clin Psychiatry; 2006 Feb 15; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [Abstract] [Full Text] [Related]
18. Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alpérovitch A. Alzheimer Dis Assoc Disord; 2008 Feb 15; 22(2):125-30. PubMed ID: 18525283 [Abstract] [Full Text] [Related]
19. [Efficacy of memantine in the treatment of Alzheimer's disease]. Molinuevo Guix JL, Lladó Plarrumaní A. Neurologia; 2005 Dec 15; 20(10):686-91. PubMed ID: 16317590 [Abstract] [Full Text] [Related]
20. [NMDA receptor antagonists: a new treatment for neuropathic pain]. Pud D, Eisenberg E. Harefuah; 1999 Apr 02; 136(7):564-7. PubMed ID: 15532603 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]